Allogeneic γδ T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic γδ T cell therapy, covering 2022-10-04 to 2022-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors [Phase 1, Phase 2]